Folic acid advisories: a public health challenge?
Daniel Herrera‐Araujo
Authors registered in the RePEc Author Service: Daniel Herrera-Araujo
Health Economics, 2016, vol. 25, issue 9, 1104-1122
Abstract:
Neural tube defects are neurological conditions affecting one in 1000 fetuses in France each year. If a fetus is affected, there is a 90% chance that the pregnancy will be terminated. Increasing folic acid intake to 400μg per day 2months before and 2months after conception reduces prevalence rates by at least 40%. In 2005, France introduced a social marketing campaign seeking to increase the intake of folic acid by to‐be‐pregnant and pregnant women through information provision. This paper sets up a quasi‐experimental setting to measure the impact of the French social marketing campaign on availability and preferences for folic acid. I combine detailed scanner data on grocery purchases with a dataset on macronutrients and micronutrients. The identification strategy exploits the variation in the usefulness of folic acid information between households: households that are pregnant or want to conceive a child use it, while those that are not pregnant do not. Results suggest evidence of a positive impact of the information campaign on folic acid household availability and preferences. A value per statistical neural tube defects case is found to be of at least 12 million. Copyright © 2016 John Wiley & Sons, Ltd.
Date: 2016
References: View references in EconPapers View complete reference list from CitEc
Citations:
Downloads: (external link)
https://doi.org/10.1002/hec.3362
Related works:
Working Paper: Folic acid advisories: a public health challenge? (2016)
Working Paper: Folic acid advisories: a public health challenge? (2016)
Working Paper: Folic acid advisories, a public health challenge? (2015) 
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:wly:hlthec:v:25:y:2016:i:9:p:1104-1122
Access Statistics for this article
Health Economics is currently edited by Alan Maynard, John Hutton and Andrew Jones
More articles in Health Economics from John Wiley & Sons, Ltd.
Bibliographic data for series maintained by Wiley Content Delivery ().